Asia
Aidea Pharma Obtains Regulatory Nod for HIV Drug Raw Material
China's drug regulator approved Jiangsu Aidea Pharmaceutical's (SHA:688488) chemical raw material application for its darunavir drug, according to a Monday filing with the Shanghai bourse.The drug is indicated for HIV-infected patients, the company said.
SHA:688488